|
|
| March 10, 2013: Dr. Mikhail Kosiborod and Dr. C. Michael Gibson discuss: Evaluation of Ranolazine in Patients With Type 2 Diabetes Melli |
Dr. Mikhail Kosiborod and Dr. C. Michael Gibson discuss: Evaluation of Ranolazine in
Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the Type 2
Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA)
Randomized Clinical Trial
TERISA was sponsored by Gilead Sciences Inc.
Saint Luke’s Mid America Heart Institute received funding for independent data analysis
from Gilead Sciences, Inc.
[ Download video ] |
|
No comments have been submitted
|